| #42 |
Shibeshih Mitiku Belachew |
Hoffmann-La Roche |
1 |
| #42 |
Simon Berner |
Straumann Holding Ag |
1 |
| #42 |
David Tagliaferri |
Basilea Pharmaceutica International Ag |
1 |
| #42 |
Celia Bel |
Roche Molecular Systems |
1 |
| #42 |
Bahaa Salem |
Novartis Ag |
1 |
| #42 |
Claire Jacob |
— |
1 |
| #42 |
Lukas Schneider |
Roche Molecular Systems |
1 |
| #42 |
Felix Aschmann |
Depuy Synthes Products |
1 |
| #42 |
Charles Doiron |
Hitachi Energy |
1 |
| #42 |
Marie Pepelnjak |
Genentech |
1 |
| #42 |
Martin Wunderlich |
Genentech |
1 |
| #42 |
Rainer E. Martin |
Hoffmann-La Roche |
1 |
| #42 |
Claudia Judith KLINTER |
Novartis Ag |
1 |
| #42 |
G Scott CHANDLER |
Genentech |
1 |
| #42 |
Silvio Blumenthal |
Straumann Holding Ag |
1 |
| #42 |
Adrian Schaeublin |
Hoffmann-La Roche |
1 |
| #42 |
Natascha HRUSCHKA |
Hoffmann-La Roche |
1 |
| #42 |
Johanna Marie WALTHER |
Hoffmann-La Roche |
1 |
| #42 |
David Leuenberger |
Csem Centre Suisse D'Electronique Et De Microtechnique Sa—Recherche Et Développement |
1 |
| #42 |
Colin Morton |
Ciba Specialty Chemicals |
1 |
| #42 |
Jörn Stitz |
4-Antibody Ag |
1 |
| #42 |
Annabelle Lemenuel |
Hoffmann-La Roche |
1 |
| #42 |
Marvin Lloyd Woodhouse |
Hoffmann-La Roche |
1 |
| #42 |
Eduardo Paulo Morawski VIANNA |
Hoffmann-La Roche |
1 |
| #42 |
Eric Legangneux |
Novartis Ag |
1 |
| #42 |
Michal Kepa |
Paul Scherrer Institut |
1 |
| #42 |
Peter KUEHL |
Hoffmann-La Roche |
1 |
| #42 |
Boram Cho |
Basf Coatings Gmbh |
1 |
| #42 |
Michaela Kneissel |
Novartis Ag |
1 |
| #42 |
Philippe Dennler |
Comet Ag |
1 |
| #42 |
Kathrin Sprecher |
Pharma Integration S.R.L. |
1 |
| #42 |
Viktor Dick |
Arxada |
1 |
| #42 |
Xu Xu |
Dsm Ip Assets B.V. |
1 |
| #42 |
Nicolas Chiaradia |
— |
1 |
| #42 |
Adrian Francios Von Muralt |
Novartis Ag |
1 |
| #42 |
Patricia Scandiucci De Freitas |
Rolic Technologies Ag |
1 |
| #42 |
Shideh REZAEIFAR |
Microsoft |
1 |
| #42 |
Radu Tanasescu |
University Of Basel |
1 |
| #42 |
Christoph Oertli |
Bombardier Transportation Gmbh |
1 |
| #42 |
Marc Sauer |
Preh Gmbh |
1 |
| #42 |
Philipp Koch |
Caltech |
1 |
| #42 |
Fabrice Aquino |
Dsm Ip Assets B.V. |
1 |
| #42 |
Vassilios Aslanis |
Novartis Ag |
1 |
| #42 |
Serge Waechter |
Franke Kaffeemaschinen Ag |
1 |
| #42 |
Kasra Shakeri-Nejad |
Novartis Ag |
1 |
| #42 |
Kaspar Rufibach |
Stanford University |
1 |
| #42 |
Dasha NELIDOVA |
Friedrich Miescher Institute For Biomedical Research |
1 |
| #42 |
Jean-Eric Charoin |
Hoffmann-La Roche |
1 |
| #42 |
Jan Michal Nebesky |
Hoffmann-La Roche |
1 |
| #42 |
Claudia Mueller |
Novartis Ag |
1 |